Prompt release of FDA guidance on mHealth urged at hearing

03/20/2013 | Clinical Innovation + Technology online

The FDA should move promptly to release its final guidance on how it intends to regulate mobile health applications to provide clarity on the issue, industry experts said during the first of three hearings being conducted this week by the House Committee on Energy & Commerce. One expert also argued that imposing the 2.3% medical device tax on mHealth apps could stymie innovation.

View Full Article in:

Clinical Innovation + Technology online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ